SCHEMBL7562167

SCHEMBL7562167

CN1CCN(CN[C]=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.43
PAOX Q6QHF9 1/20 0.35
MC4R P32245 1/20 0.33
SIGMAR1 Q99720 3/20 0.33
HDAC6 Q9UBN7 2/20 0.33
ALOX15 P16050 1/20 0.32
HDAC2 Q92769 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 2/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
CSNK2A1 P68400 1/20 0.32
CSNK2A3 Q8NEV1 1/20 0.32
CYP2D6 P10635 1/20 0.32
TMEM97 Q5BJF2 1/20 0.32
LMNA P02545 1/20 0.31
TDP1 Q9NUW8 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1259915 0.80
SCHEMBL1259596 0.80
SCHEMBL1785086 0.79 HDAC2 (0.41) PAOXSIGMAR1HDAC6HDAC2HDAC8
SCHEMBL1259338 0.78 NPSR1 (0.39) NPSR1CYP1A2LMNA
SCHEMBL3927123 0.76 PAOX (0.44) PAOXSIGMAR1HDAC6HDAC2HDAC8
SCHEMBL3721903 0.74 KDM4E (0.40) NPSR1ALOX15KDM4E
SCHEMBL6007437 0.74 POLB (0.39) NPSR1SIGMAR1
SCHEMBL9602885 0.74 NPSR1 (0.37) NPSR1KDM4E
SCHEMBL7562171 0.74 NPSR1 (0.37) NPSR1PAOXMC4RSIGMAR1HDAC6
SCHEMBL4393264 0.74 NPSR1 (0.39) NPSR1PAOXMC4RSIGMAR1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0691961-B1 SUBSTITUTED CAPROLACTAMS AND DERIVATIVES THEREOF USEFUL FOR TREATMENT OF HIV DISEASE DU PONT PHARM CO (US) 2002-02-13 EP claimed
EP-0686151-B1 SUBSTITUTED CYCLIC CARBONYLS AND DERIVATIVES THEREOF USEFUL AS RETROVIRAL PROTEASE INHIBITORS DU PONT PHARM CO (US) 2000-07-05 EP claimed
EP-0830349-B1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS DU PONT PHARM CO (US) 2000-03-22 EP claimed
EP-0830349-A1 METHOD FOR PREPARING N, N'-DISUBSTITUED CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-03-25 EP disclosed